Broad Institute Uses AI to Design New Antibiotics and Predict Drug Toxicity
• The Broad Institute is leveraging artificial intelligence to accelerate drug discovery, designing new antibiotics and predicting drug toxicity with greater accuracy than traditional methods. • The AI systems are also being applied to identify specific genes, molecules, and cells that might serve as therapeutic targets for disease treatment. • This computational approach promises to dramatically speed up the drug development pipeline and reduce the cost and time required to bring new medications to patients.
Read original · broadinstitute.org







